Pivotal Phase 2 Trial Results The pivotal Phase 2 trial, published by Jastreboff and colleagues in the New England Journal of Medicine in August 2023, enrolled 338 adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related comorbidity but without diabetes
4.3 GLP-1s effect on bone metabolism in humans Compared to rodents, results from human studies are inconsistent
It is not typically recommended to drink alcohol while taking Ozempic, metformin, or other diabetes medications
Higher NO levels are associated with higher risk of asthma, asthma severity, and greater response to bronchodilator agents [22, 26]
replacing URLs with httpurl
It is FDA-approved for use in Type 2 diabetes, as well as to reduce cardiovascular risk in certain patients